EVEROLIMUS PLUS OCTREOTIDE LAR IN PATIENTS WITH LUNG CARCINOIDS

EVEROLIMUS PLUS OCTREOTIDE LAR IN PATIENTS WITH LUNG CARCINOIDS

Bibliographic Details
Main Authors:	Granberg, D, Fazio, N, Grossman, A, Saletan, S, Pannnerselvam, A, Wolin, E
Format:	Journal article
Published:	2014

Similar Items

Effect of Everolimus plus Octreotide LAR in Patients With Advanced Lung Neuroendocrine Tumours - Analysis From RADIANT-2
by: Fazio, N, et al.
Published: (2011)

Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study.
by: Fazio, N, et al.
Published: (2013)

Everolimus in combination with octreotide LAR in thymic atypical carcinoid
by: Tadashi Sakane, et al.
Published: (2023-05-01)

Metastatic Recurrence of Typical Pulmonary Carcinoid Accompanied by Carcinoid Syndrome, Successfully Treated with Octreotide LAR
by: Asako Yanagisawa, et al.
Published: (2017-01-01)

90Y-edotreotide for metastatic carcinoid refractory to octreotide.
by: Bushnell, D, et al.
Published: (2010)

A comparison of lanreotide and octreotide LAR for treatment of acromegaly.
by: Turner, H, et al.
Published: (1999)

The efficacy of octreotide LAR in acromegalic patients as primary or secondary therapy
by: Zelija Velija-Asimi
Published: (2012-02-01)

Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying?
by: Ramírez, C, et al.
Published: (2012)

Long lasting octreotide LAR therapy in large cell neuroendocrine carcinoma (LCNEC) of the lung
by: Alfredo Butera
Published: (2015-10-01)

Role of high dose octreotide LAR for the treatment of GEP-NETs
by: Giulia M. Franchi, et al.
Published: (2009-03-01)

Long lasting octreotide LAR therapy in non functioning pancreatic neuroendocrine carcinoma
by: Ivan Lolli, et al.
Published: (2015-10-01)

Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.
by: Turner, H, et al.
Published: (2004)

Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly.
by: Turner, H, et al.
Published: (1999)

A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
by: Bomanji, J, et al.
Published: (1992)

Long-standing malignant pancreatic carcinoid treated with octreotide Carcinoide pancreático maligno de larga evolución tratado con octeotrida
by: M. J. Varas-Lorenzo
Published: (2010-11-01)

Population Pharmacokinetic Modelling of the Complex Release Kinetics of Octreotide LAR: Defining Sub-Populations by Cluster Analysis
by: Iasonas Kapralos, et al.
Published: (2021-09-01)

Octreotide therapy in a patient with lung microcytoma
by: Daniela Adua, et al.
Published: (2015-10-01)

Prolonged progression‐free survival achieved by octreotide LAR plus transarterial embolization in low‐to‐intermediate grade neuroendocrine tumor liver metastases with high hepatic tumor burden
by: Yiming Liu, et al.
Published: (2022-07-01)

Pharmacokinetic and technical comparison of Sandostatin<sup>® </sup>LAR<sup>® </sup>and other formulations of long-acting octreotide
by: Bizec Jean-Claude, et al.
Published: (2011-09-01)

Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study.
by: Lukas Kirzinger, et al.
Published: (2016-01-01)

Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib.
by: Andrés F Cardona, et al.
Published: (2019-01-01)

Efficacy and safety of everolimus treatment in a hemodialysis patient with metastatic atypical bronchial carcinoid: case report and literature review
by: M. P. Brizzi, et al.
Published: (2018-03-01)

Successful application of technetium-99m-labeled octreotide acetate scintigraphy in the detection of ectopic adrenocorticotropin-producing bronchial carcinoid lung tumor: a case report
by: Fallahi Babak, et al.
Published: (2010-10-01)

Uneventful octreotide LAR therapy throughout three pregnancies, with favorable delivery and anthropometric measures for each newborn: a case report
by: Naccache Deeb, et al.
Published: (2011-08-01)

Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.
by: Grozinsky-Glasberg, S, et al.
Published: (2008)

First Case of Regression of Carcinoid Heart Disease on Serial Transthoracic Echocardiograms following Octreotide Monotherapy in a Patient with Metastatic Pancreatic Neuroendocrine Tumor
by: Ermin Nath, et al.
Published: (2020-12-01)

Everolimus and long acting octreotide as a volume reducing treatment of polycystic livers (ELATE): study protocol for a randomized controlled trial
by: Chrispijn Melissa, et al.
Published: (2011-11-01)

Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Systematic and Critical Review of the Literature
by: Peri M, et al.
Published: (2020-07-01)

The molecular pathogenesis and management of bronchial carcinoids.
by: Cakir, M, et al.
Published: (2011)

Everolimus therapy for progressive adrenocortical cancer
by: Fraenkel, M, et al.
Published: (2013)

Everolimus therapy for progressive adrenocortical cancer.
by: Fraenkel, M, et al.
Published: (2013)

IGF2-induced hypoglycemia unresponsive to everolimus.
by: Korevaar, T, et al.
Published: (2014)

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2001)

ACTH-ectopic syndrome in patient with lung carcinoid
Published: (2009-09-01)

Rare case of rectal carcinoid with synchronous primary carcinoid tumors of the lung misdiagnosed as lung metastases
by: Fuminori Teraishi, et al.
Published: (2024-07-01)

Lar, doce lar?
by: Silvia Scoralich de Carvalho
Published: (2023-08-01)

Carcinoid tumorlet/typical carcinoid of the lung: An incidental bronchoscopic finding and cytological dilemma
by: Ankit Pandey, et al.
Published: (2024-01-01)

Therapeutic applications of octreotide in pediatric patients
by: Abdulrahman Al-Hussaini, et al.
Published: (2012-01-01)

Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial.
by: Norberto Perico, et al.
Published: (2019-04-01)

Long-Term Efficacy of S-1 Chemotherapy plus Administration of Octreotide for a Patient with Metastatic Neuroendocrine Tumor (Gastrinoma)
by: Sakura Hiraide, et al.
Published: (2017-05-01)